NEURO: Depression Flashcards

1
Q

Generally, what are some effects of mental illness of the patient, the family and society.

A

Effects of Psychological Disorders on the Patient:
Individuals with psychological disorders are at greater risk for decreased quality of life, educational difficulties, lowered productivity and poverty, social problems, vulnerability to abuse, and additional health problems.

Effects of Psychological Disorders on Families/Caregivers:
The burden of caring for a mentally ill individual often falls on the patient’s immediate family or relatives. Families and caregivers of individuals with psychological disorders are often unable to work at full capacity due to the demands of caring for a mentally ill individual, leading to decreased economic output and a reduction in household income

Effects of Psychological Disorders on Society:
In 2001, the WHO estimated that mental health problems cost developed nations between three and four % of their GNP (gross national product).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Discuss the different treatments for mental illness.

A

Examples of treatment for mental illness is cognitive behavioural therapy and pharmacotherapy.

Although these drugs have certainly helped a lot of people and we are in a better place from where we were 30 years ago, there are still major problems. They do not help everyone (resistance), side effects can be severe in some cases, tolerance, dependence, have a narrow therapeutic window and they do not treat all symptoms.
All this made developing drugs for treating mental disorders expensive and difficult and many pharma have got out of this CNS business.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List some characteristics of affective disorders.

A
  • disorders of mood rather than thought / cognition
  • most common is depression
  • major cause of premature death and disability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the two types of depression.

A

1) UNIPOLAR DEPRESSION:
- mood swings in one direction
- most common depressive illness
- 75% cases REACTIVE (induced by environmental factors)
- 25% cases ENDOGENOUS (genetic)

2) BIPOLAR DEPRESSION:
- Oscillation between depression and mania
- Mania: excessive exuberance, enthusiasm, self confidence, impulsive actions, aggression, irritability, delusions of grandiose
- less common
- onset usually in adult life
- strong hereditary tendency (no genes found yet)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is depression?

A

There are multiple ways to define it:

DEPRESSIVE DISORDER: a low state marked by significant levels of sadness, lack of energy, low self-worth, guilt or related syndromes

MAJOR DEPRESSIVE DISORDER: severe pattern of depression that is disabling and is not caused by factors such as drugs or a general medical condition

DYSTHYMIC DISORDER (DYSTHYMIA): similar to major depressive disorder but less severe/disabling and more long-lasting (chronic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why is diagnosing depression hard?

A
  • wide variety of symptoms that patients can report
  • difficult to know when a normal fluctuation in mood becomes depression
  • no single objective test to establish diagnosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some symptoms of depression?

A

EMOTIONAL SYMPTOMS (Q):

  • apathy, pessimism, negativity
  • low self esteem, feeling guilty
  • loss of motivation
  • indecisiveness

BIOLOGICAL SYMPTOMS (Q):

  • reduced activity
  • loss of libido
  • sleep disturbance
  • loss of appetite
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are some screening questions you could ask in a clinical interview?

A
  • During the past month have you often been bothered by feeling down, depressed or hopeless?
  • During the past month have you often been bothered by having little interest or pleasure in doing things?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Who gets depression?

A

GENDER:

  • depression affects around twice as many females as males
  • lifetime prevalence of major depression: 10-25 % for women, 5-12 % for men

AGE:

  • 1st episode of depression usually late adolescence of early adulthood
  • age of onset has been decreasing in recent years
  • is life now more stressful?
  • are we just diagnosing more people with depression?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some important factors to consider when dealing with depression?

A

SUICIDE:

  • suicidal thoughts are common among depressed patients
  • 20% depressed individuals will attempt suicide
  • 10% of severe depressives will commit suicide

COMORBIDITY:
- depression is often comorbid with other psychiatric conditions (e.g. withdrawal from drugs of abuse)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

With co-morbidity, what are some general medical conditions in which you often find depression?

A
  • terminal illness
  • chronic illness (e.g. chronic pain)
  • thyroid dysfunction
  • neurological disease
  • stroke
  • drug abuse
  • Parkinson’s disease
  • anxiety
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What can cause depression?

A

GENETIC PREDISPOSITION?

  • General population: 3.2%
  • First degree relatives of patients: 20%
  • Monozygotic twins: 40-50%

ENVIRONMENTAL FACTORS?

  • Loss
  • Environmental stressors
  • Social isolation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the different theories of depression?

A
  • the monoamine theory

- the neuroendocrine theory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the major theory of depression?

Describe it.

A

The major theory of depression is the monoamine theory.

  • there is an overall reduced activity of central noradrenergic and / or serotonergic systems
  • reserpine depletes the brain of NA and 5-HT, inducing depression
  • the main antidepressant drugs [amines] act in the brain (Q devise drugs to treat depression)

The lower activity of noradrenergic system leads to an increase in post synaptic receptors. Blocking reuptake to increased amines in synaptic cleft normalises postsynaptic receptor number.
[NA]plasma tends to be higher in depressed patients than in normals – as an increase in anxiety, causes an increase sympathetic activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is some evidence against the monoamine theory?

A
  • Difficult to show deficits in brain [NA] & [5-HT] and functioning/ (-) results from CSF, plasma in depressed /individuals respond better to one AD than another
  • Most antidepressant drugs take several weeks for therapeutic effect, but an increase in amines is acute (secondary adaptive changes more important)
  • Some antidepressants are weak/have no effect on amine uptake (e.g trazodone)/no increase in 5HT and NA but they are still antidepressants!
  • Cocaine blocks amine uptake but has no antidepressant effect
  • Decrease in 5HT in dipolar linked to aggression rather than depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the neuroendocrine theory of depression.

A

THE HPA AXIS:

  • NAergic & 5-HT neurons input to hypothalamus
  • Hypothalamus releases corticotropin-releasing hormone (CRH)
  • CRH acts on pituitary – release of adrenocorticotrophic hormone (ACTH)
  • Cortisol release from adrenal cortex in response to increased ACTH in blood

Amygdala activation stimulates the HPA system but hippocampal activation suppresses the HPA system. Thus, if the system is in disarray, we can get an increase in cortisol which can lead to depression, so we need to consider the amygdala and the hippocampus.

Imaging studies have provided evidence of neuronal loss in depression and a decrease of this loss with AD drugs.
5-HT mediates neurogenesis during development via brain-derived neurotrophic factor (BDNF).

Tactile stimulation just after birth activates 5-HT pathways to hippocampus. 5-HT triggers long-lasting increase in expression of glucocorticoid receptor gene, which leads to an increase in glucocorticoid receptors in hippocampus.

It still appears that monoamine is main theory to explain depression – but needs to be extended e.g. perhaps monoamine hypofunction and CRH hyperfunction with some neuronal loss.

17
Q

What are some proofs of neuroplasticity and neurogenesis as a theory of depression?

A
  • Evidence of neuronal loss and decreased neuronal activity in hippocampus and prefrontal cortex (decision making centres)
  • Antidepressants and electroconvulsive therapy (ECT) promote neurogenesis in these regions
  • 5-HT promotes neurogenesis during development (BDNF: brain-derived neurotrophic factor)
  • Increase in Glutamate in the cortex of depressed people (NMDA antagonists potential for depression treatment e.g. ketamine)
18
Q

What are some treatments of affective disorders?

A

ELECTROCONVULSIVE THERAPY (ECT):

  • localised electrical stimulation
  • some evidence of neurogenesis, possible involvement of hippocampus
  • adverse effect: memory loss

PSYCHOTHERAPY:

  • mild to moderate depression
  • overcome negative views

ANTIDEPRESSANTS:

  • tricyclic antidepressants (TCA), block reuptake of NA and 5-HT (imipramine)
  • selective serotonin (5-HT) reuptake inhibitors (SSRI) (fluoxetine)
  • NA-selective reuptake inhibitors (reboxetine)
  • monoamine oxidase inhibitors (MAOI), block degradation of NA and 5-HT (phenelzine)

[All elevate monoamine levels but antidepressant effect takes several weeks]

19
Q

What are some points about using antidepressants to combat affective disorders?

A
  • Increase in monoamines may ‘normalise’ presynaptic and postsynaptic receptors
  • Antidepressants dampen down HPA axis hyperactivity: increased hippocampal glucocorticoid receptor expression
  • SSRIs may promote neurogenesis
20
Q

How can we combat social phobia?

A

After its discovery, the next hypothesis was “if oxytocin has a prosocial effect, then externally administered OXT should be able reverse social deficits”. This was tested in rats.

Brain oxytocin (OXT) reverses defeat-induced social phobia in rodents. 30 min exposure to social defeat (20 min before social preference testing) prevents social preference and results in social avoidance in vehicle-treated rats. Social phobia can be reversed by intracerebroventricular infusion of OXT 20 min before behavioural testing.

21
Q

How can lithium be used to treat affective disorders?

A
  • it stabilises the mood (mania and depression)

- it inhibits enzymes involved in signal transduction